A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes

Journal of Nuclear Medicine

Volumn 51, Issue 1, 2010, Pages 92-97

  Tekabe, Yared ^a   Luma, Joane ^a   Einstein, Andrew J ^a   Sedlar, Marija ^a   Li, Qing ^a   Schmidt, Ann Marie ^a   Johnson, Lynne L ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

ApoE mice; Atherosclerosis; Diabetes; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOLIPOPROTEIN E; MONOCLONAL ANTIBODY; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG UPTAKE; HISTOPATHOLOGY; IN VIVO STUDY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STREPTOZOCIN DIABETES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHELATING AGENTS; DIABETES COMPLICATIONS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOGLOBULIN FAB FRAGMENTS; ISOTOPE LABELING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 75149138353     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.064659     Document Type: Article

References (19)

1. ε-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation endproducts that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274: 31740-31749.
2. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889-901.
3. Schmidt AM, Yan SD, Brett J, et al. Regulation of human mononuclear phagocyte migration by cell surface binding proteins for AGE. J Clin Invest. 1993;91:2155-2168.
4. Burke AP, Kolodgie FD, Zieske A, et al. Morphologic findings of coronary atherosclerotic plaques in diabetes. Arterioscler Thromb Vasc Biol. 2004;24:1266-1271.
5. Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108: 1070-1077.
6. Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation endproducts in tissues. Am J Pathol. 1993;143:1699-1722.
7. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD. S100P stimulates cell proliferation and survival via receptor for advanced glycation end products (RAGE). J Biol Chem. 2004;279:5059-5065.
8. Bucciarelli LG, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation. 2002;106: 2827-2835.
9. Park L, Raman KG, Lee KJ, et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med. 1998;4:1025-1031.
10. Tekabe Y, Li Q, Rosario R, et al. Development of RAGE-directed imaging of atherosclerosis plaque in a murine model of spontaneous atherosclerosis. Circ Cardiovasc Imaging. 2008;1:212-219.
11. Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation endproducts (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113:1641-1650.
12. Candido R, Jandeleit-Dahm KA, Cao Z, et al. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 2002;106:246-253.
13. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation endproducts of proteins. J Biol Chem. 1992;267:14998-15004.
14. Hnatowich DJ, Layne WW, Childs RL, et al. Radioactive labeling of antibody: a simple and efficient method. Science. 1983;220:613-615.
15. Forrer F, Valkema R, Bernard B, et al. In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals. Eur J Nucl Med Mol Imaging. 2006;33:1214-1217.
16. Daugherty A, Whitman SC. Quantification of atherosclerosis in mice. In: Hofker MH, van Duersen J, eds. Transgenic Mouse Methods and Protocols. Totowa, NJ: Humana Press; 2003:293-307.
17. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301.
18. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma. Circulation. 2003;108:3134-3139.
19. Schäfers M, Remann B, Kopha K, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004;109: 2554-2559.